Federal Magistrate Judge Michael Merz of Ohio focused heavily on the use of one of the drugs, midazolam, citing evidence from multiple other state executions that the drug insufficiently sedated inmates, likely leading to suffering during their executions.
Lawyers for three Ohio death row inmates claimed such suffering violated the US Constitution's Eighth Amendment prohibition against cruel and unusual punishment. Judge Merz sided with that argument, saying the proposed three-drug lethal injection cocktail "creates a substantial risk of serious harms."
In a 119-page ruling, the judge cited recent executions in Ohio, Alabama, Arizona and elsewhere, where inmates receiving midazolam as the first drug in a lethal injection cocktail appeared to remain conscious for a substantial period of time.
Ohio halted executions after the 2014 lethal injection of Dennis McGuire using midazolam, during which the inmate appeared to snort and gasp. Judge Merz pointed to witness testimony from that execution, including from Columbus Dispatch reporter Alan Johnson, who has witnessed 20 executions in total.
The state countered that the revised dosage of midazolam would be 50 times stronger. But the judge pointed to expert testimony offered by the plaintiffs that midazolam was not an adequate substitute for general anesthesia drugs.
Its use in executions is "contrary to sound medical or scientific reasoning," testified Craig Stevens, professor of pharmacology at Oklahoma State University, according to the court.
States have struggled to find adequate supplies of lethal injection drugs, as pharmaceutical companies have restricted the use of their drugs for executions.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
